Khan Irtaza, Chatterjee Arjun B, Bellinger Christina R, Haponik Edward
Salem Chest Specialists, Winston-Salem, N.C., USA.
Respiration. 2016;92(3):158-65. doi: 10.1159/000448250. Epub 2016 Sep 6.
Bronchoscopy is a safe and minimally invasive diagnostic tool, but no studies have reported prospectively on sedation and outcomes in patients with objectively defined obesity.
The purpose of the study is to determine if obese patients require more sedation or had more procedural complications during bronchoscopy under moderate sedation than non-obese patients.
We evaluated complications and sedation requirements in non-obese versus obese patients, defined by multiple criteria including body mass index (BMI), neck circumference, abdominal height, and Mallampati scores.
Data were collected prospectively in 258 patients undergoing bronchoscopy under moderate sedation. By varying criteria, there were the following proportions of obese patients: 30% by BMI >30, 39% by neck circumference >40 cm, and 35% by abdominal height >22 cm in males and >20 cm in females. Sedative and analgesic dosing was not clinically significantly higher in obese patients than in non-obese patients. There was no difference in complications or procedural success based on obesity criteria. Hemoglobin oxygen desaturations occurred more often during bronchoscopy in patients with increasing Mallampati scores (p = 0.04), but this had no effect on bronchoscopy time or successful completion of the procedure. A subset of patients with previous polysomnogram-proven obstructive sleep apnea were more likely to have earlier termination of their procedure (15.8%) than patients with no diagnosed sleep apnea (2.3%; p = 0.002).
In this prospective assessment of patients with obesity, we found neither clinically significant differences in sedation needs nor increases in complications in obese versus non-obese patients using a variety of indices of obesity.
支气管镜检查是一种安全且微创的诊断工具,但尚无研究前瞻性报道客观定义的肥胖患者的镇静情况及结果。
本研究旨在确定肥胖患者在中度镇静下进行支气管镜检查时是否比非肥胖患者需要更多的镇静或有更多的操作并发症。
我们评估了非肥胖患者与肥胖患者的并发症和镇静需求,肥胖由包括体重指数(BMI)、颈围、腹围和马兰帕蒂评分在内的多种标准定义。
前瞻性收集了258例接受中度镇静下支气管镜检查患者的数据。根据不同标准,肥胖患者的比例如下:BMI>30者占30%,颈围>40 cm者占39%,男性腹围>22 cm、女性腹围>20 cm者占35%。肥胖患者的镇静和镇痛剂量在临床上并不显著高于非肥胖患者。基于肥胖标准,并发症或操作成功率没有差异。马兰帕蒂评分增加的患者在支气管镜检查期间血红蛋白氧饱和度下降更频繁(p = 0.04),但这对支气管镜检查时间或操作的成功完成没有影响。一部分先前经多导睡眠图证实患有阻塞性睡眠呼吸暂停的患者比未诊断出睡眠呼吸暂停的患者更有可能提前终止操作(15.8%比2.3%;p = 0.002)。
在这项对肥胖患者的前瞻性评估中,我们发现使用多种肥胖指标时,肥胖患者与非肥胖患者在镇静需求上没有临床显著差异,并发症也没有增加。